The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment
- PMID: 38691217
- DOI: 10.1007/s10792-024-03152-3
The effect of adjuvant Mitomycin C during vitrectomy on functional and anatomical outcomes in patients with severe diabetic tractional retinal detachment
Abstract
Purpose: To evaluate the effect of adjuvant Mitomycin C (MMC) use on the anatomical and functional success of vitreoretinal surgery (VRS) in severe diabetic tractional retinal detachment (dTRD) patients.
Methods: A retrospective analysis of consecutive patients undergoing VRS due to severe dTRD was conducted. Patients were categorized into those who received 20 µg/0.1 mL MMC via MMC sandwich method (Group 1) and those who did not (Group 2). Demographics, surgical characteristics, visual outcomes, and complications that may related to MMC were analyzed.
Results: A total of 25 eyes were included, 13 in Group 1 and 12 in Group 2. No statistical difference was observed in baseline characteristics between the groups. The mean best-corrected visual acuity was 1.90 ± 0.43 logMAR and 1.93 ± 0.41 logMAR preoperatively and 1.60 ± 0.78 logMAR and 1.56 ± 0.78 logMAR postoperatively in Groups 1 and 2, respectively (p = 0.154). The postoperative mean intraocular pressure was 16.23 ± 2.55 mmHg and 13.08 ± 4.94 mmHg in Groups 1 and 2, respectively (p = 0.225). The rate of re-surgery was significantly lower in Group 1 (0% vs. 41.7% in Group 2, p = 0.015). Retina was attached in all patients at the last visit. No MMC-related complication was recorded.
Conclusion: Intraoperative adjuvant MMC application for severe dTRD significantly reduces re-surgery rates with good anatomical and functional outcomes safely.
Keywords: Fibrovascular proliferation; Mitomycin C; Proliferative diabetic retinopathy; Vitrectomy.
© 2024. The Author(s), under exclusive licence to Springer Nature B.V.
Similar articles
-
Visual and anatomical outcomes of primary retinectomy for diabetic tractional retinal detachment.BMC Ophthalmol. 2025 Apr 17;25(1):216. doi: 10.1186/s12886-025-04065-0. BMC Ophthalmol. 2025. PMID: 40247269 Free PMC article.
-
Pars plana vitrectomy and panretinal photocoagulation combined with trabeculectomy for successful treatment of neovascular glaucoma.Graefes Arch Clin Exp Ophthalmol. 2006 Dec;244(12):1627-32. doi: 10.1007/s00417-006-0321-7. Graefes Arch Clin Exp Ophthalmol. 2006. PMID: 16639623
-
Surgical and visual outcome following 20-gauge vitrectomy in proliferative diabetic retinopathy over a 10-year period, evidence for change in practice.Eye (Lond). 2012 Apr;26(4):576-82. doi: 10.1038/eye.2011.348. Epub 2012 Jan 13. Eye (Lond). 2012. PMID: 22241020 Free PMC article.
-
Anti-vascular endothelial growth factors in combination with vitrectomy for complications of proliferative diabetic retinopathy.Cochrane Database Syst Rev. 2023 May 31;5(5):CD008214. doi: 10.1002/14651858.CD008214.pub4. Cochrane Database Syst Rev. 2023. PMID: 37260074 Free PMC article. Review.
-
Outcomes and Complications of Pars Plana Vitrectomy for Tractional Retinal Detachment in People With Diabetes: A Systematic Review and Meta-analysis.JAMA Ophthalmol. 2023 Feb 1;141(2):186-195. doi: 10.1001/jamaophthalmol.2022.5817. JAMA Ophthalmol. 2023. PMID: 36633878 Free PMC article.
Cited by
-
Effect of Adjuvant Mitomycin-C on Recurrent Rhegmatogenous Retinal Detachment With Proliferative Vitreoretinopathy Managed by Relaxing Retinotomy and Retinectomy.J Ophthalmol. 2025 Mar 19;2025:9927416. doi: 10.1155/joph/9927416. eCollection 2025. J Ophthalmol. 2025. PMID: 40144767 Free PMC article.
-
Elucidating postoperative dynamics in tractional retinal detachment: a systematic review and meta-analysis of structural and functional outcomes following diabetic vitrectomy, including an analysis of postoperative complications.BMC Ophthalmol. 2024 Dec 24;24(1):547. doi: 10.1186/s12886-024-03820-z. BMC Ophthalmol. 2024. PMID: 39719566 Free PMC article.
-
Enhancing the outcomes of diabetic vitrectomy with pharmacological adjuvants.World J Methodol. 2025 Jun 20;15(2):98912. doi: 10.5662/wjm.v15.i2.98912. eCollection 2025 Jun 20. World J Methodol. 2025. PMID: 40548210 Free PMC article.
References
-
- The Diabetic Retinopathy Vitrectomy Study Research Group (1988) Early vitrectomy for severe proliferative diabetic retinopathy in eyes with useful vision; clinical application of results of a randomized trial:diabetic retinopathy vitrectomy study report 4. Ophthalmology 95(10):1321–1334. https://doi.org/10.1016/s0161-6420(88)33014-9 - DOI
-
- McCullough P, Mohite A, Virgili G, Lois N (2023) Outcomes and complications of pars plana vitrectomy for tractional retinal detachment in people with diabetes: a systematic review and meta-analysis. JAMA Ophthalmol 141(2):186–195. https://doi.org/10.1001/jamaophthalmol.2022.5817 - DOI - PubMed - PMC
-
- Al-Khersan H, Venincasa MJ, Kloosterboer A, Sridhar J, Smiddy WE, Townsend JH et al (2020) Pars plana vitrectomy reoperations for complications of proliferative diabetic retinopathy. Clin Ophthalmol (Auckland, NZ) 14:1559–1563. https://doi.org/10.2147/opth.s252285 - DOI
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical